Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
企業コードINMD
会社名Inmode Ltd
上場日Aug 08, 2019
最高経営責任者「CEO」Mr. Moshe Mizrahy
従業員数599
証券種類Ordinary Share
決算期末Aug 08
本社所在地Tavor Building, Sha'ar Yokneam
都市YOKNEAM
証券取引所NASDAQ Global Select Consolidated
国Israel
郵便番号2069200
電話番号97249097470
ウェブサイトhttps://inmodemd.com/
企業コードINMD
上場日Aug 08, 2019
最高経営責任者「CEO」Mr. Moshe Mizrahy
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし